Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 303

1.

Recommendations for systemic antimicrobial therapy in fracture-related infection: a consensus from an international expert group.

Depypere M, Kuehl R, Metsemakers WJ, Senneville E, McNally MA, Obremskey WT, Zimmerli W, Atkins BL, Trampuz A; Fracture-Related Infection (FRI) Consensus Group.

J Orthop Trauma. 2019 Sep 27. doi: 10.1097/BOT.0000000000001626. [Epub ahead of print]

PMID:
31567902
2.

Pathogenesis and management of fracture-related infection.

Depypere M, Morgenstern M, Kuehl R, Senneville E, Moriarty TF, Obremskey WT, Zimmerli W, Trampuz A, Lagrou K, Metsemakers WJ.

Clin Microbiol Infect. 2019 Aug 22. pii: S1198-743X(19)30447-1. doi: 10.1016/j.cmi.2019.08.006. [Epub ahead of print] Review.

PMID:
31446152
3.

A Trans-Atlantic Perspective on Stagnation in Clinical Translation of Antimicrobial Strategies for the Control of Biomaterial-Implant-Associated Infection.

Busscher HJ, Alt V, van der Mei HC, Fagette PH, Zimmerli W, Moriarty TF, Parvizi J, Schmidmaier G, Raschke MJ, Gehrke T, Bayston R, Baddour LM, Winterton LC, Darouiche RO, Grainger DW.

ACS Biomater Sci Eng. 2019 Feb 11;5(2):402-406. doi: 10.1021/acsbiomaterials.8b01071. Epub 2018 Dec 2. Review.

4.

Dihydrotestosterone is a predictor for mortality in males with community-acquired pneumonia: results of a 6-year follow-up study.

Zurfluh S, Nickler M, Ottiger M, Steuer C, Kutz A, Christ-Crain M, Zimmerli W, Thomann R, Hoess C, Henzen C, Bernasconi L, Huber A, Mueller B, Schuetz P; proHOSP study group.

Respir Res. 2018 Dec 4;19(1):240. doi: 10.1186/s12931-018-0947-0.

5.

Role of Rifampin against Staphylococcal Biofilm Infections In Vitro, in Animal Models, and in Orthopedic-Device-Related Infections.

Zimmerli W, Sendi P.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01746-18. doi: 10.1128/AAC.01746-18. Print 2019 Feb. Review.

6.

General Assembly, Prevention, Antimicrobials (Systemic): Proceedings of International Consensus on Orthopedic Infections.

Bondarenko S, Chang CB, Cordero-Ampuero J, Kates S, Kheir M, Klement MR, McPherson E, Morata L, Silibovsky R, Skaliczki G, Soriano A, Suárez R, Szatmári A, Webb J, Young S, Zimmerli W.

J Arthroplasty. 2019 Feb;34(2S):S61-S73. doi: 10.1016/j.arth.2018.09.055. Epub 2018 Oct 19. No abstract available.

PMID:
30348584
7.

Hip and Knee Section, Treatment, Antimicrobials: Proceedings of International Consensus on Orthopedic Infections.

Anemüller R, Belden K, Brause B, Citak M, Del Pozo JL, Frommelt L, Gehrke T, Hewlett A, Higuera CA, Hughes H, Kheir M, Kim KI, Konan S, Lausmann C, Marculescu C, Morata L, Ramirez I, Rossmann M, Silibovsky R, Soriano A, Suh GA, Vogely C, Volpin A, Yombi J, Zahar A, Zimmerli W.

J Arthroplasty. 2019 Feb;34(2S):S463-S475. doi: 10.1016/j.arth.2018.09.032. Epub 2018 Oct 19. No abstract available.

PMID:
30348582
8.

Hip and Knee Section, What is the Definition of a Periprosthetic Joint Infection (PJI) of the Knee and the Hip? Can the Same Criteria be Used for Both Joints?: Proceedings of International Consensus on Orthopedic Infections.

Shohat N, Bauer T, Buttaro M, Budhiparama N, Cashman J, Della Valle CJ, Drago L, Gehrke T, Marcelino Gomes LS, Goswami K, Hailer NP, Han SB, Higuera CA, Inaba Y, Jenny JY, Kjaersgaard-Andersen P, Lee M, Llinás A, Malizos K, Mont MA, Jones RM, Parvizi J, Peel T, Rivero-Boschert S, Segreti J, Soriano A, Sousa R, Spangehl M, Tan TL, Tikhilov R, Tuncay I, Winkler H, Witso E, Wouthuyzen-Bakker M, Young S, Zhang X, Zhou Y, Zimmerli W.

J Arthroplasty. 2019 Feb;34(2S):S325-S327. doi: 10.1016/j.arth.2018.09.045. Epub 2018 Oct 22. No abstract available.

PMID:
30343971
9.

Association of the Tyrosine/Nitrotyrosine pathway with death or ICU admission within 30 days for patients with community acquired pneumonia.

Baumgartner T, Zurauskaité G, Wirz Y, Meier M, Steuer C, Bernasconi L, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Mueller B, Schuetz P.

BMC Infect Dis. 2018 Aug 24;18(1):423. doi: 10.1186/s12879-018-3335-y.

10.

Are We Winning or Losing the Battle With Periprosthetic Joint Infection: Trends in Periprosthetic Joint Infection and Mortality Risk for the Medicare Population.

Kurtz SM, Lau EC, Son MS, Chang ET, Zimmerli W, Parvizi J.

J Arthroplasty. 2018 Oct;33(10):3238-3245. doi: 10.1016/j.arth.2018.05.042. Epub 2018 Jun 1.

PMID:
29914821
11.

Association of adrenal hormone metabolites and mortality over a 6-year follow-up in COPD patients with acute exacerbation.

Zurfluh S, Nickler M, Ottiger M, Steuer C, Kutz A, Christ-Crain M, Zimmerli W, Thomann R, Hoess C, Henzen C, Bernasconi L, Huber A, Mueller B, Schuetz P.

Clin Chem Lab Med. 2018 Mar 28;56(4):669-680. doi: 10.1515/cclm-2017-0873.

PMID:
29220883
12.

Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.

Ottiger M, Nickler M, Steuer C, Bernasconi L, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Mueller B, Schuetz P.

Nutrition. 2018 Jan;45:135-141.e1. doi: 10.1016/j.nut.2017.07.001. Epub 2017 Jul 6.

PMID:
28870405
13.

Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Vögeli A, Ottiger M, Meier MA, Steuer C, Bernasconi L, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Mueller B, Schuetz P.

Lung. 2017 Dec;195(6):717-727. doi: 10.1007/s00408-017-0047-9. Epub 2017 Aug 29.

PMID:
28852826
14.

Activation of the Serotonin Pathway is Associated with Poor Outcome in COPD Exacerbation: Results of a Long-Term Cohort Study.

Meier MA, Ottiger M, Vögeli A, Steuer C, Bernasconi L, Thomann R, Christ-Crain M, Henzen C, Hoess C, Zimmerli W, Huber A, Mueller B, Schuetz P.

Lung. 2017 Jun;195(3):303-311. doi: 10.1007/s00408-017-0004-7. Epub 2017 Apr 22.

PMID:
28434116
15.

Orthopaedic biofilm infections.

Zimmerli W, Sendi P.

APMIS. 2017 Apr;125(4):353-364. doi: 10.1111/apm.12687. Review.

PMID:
28407423
16.

The Not-So-Good Prognosis of Streptococcal Periprosthetic Joint Infection Managed by Implant Retention: The Results of a Large Multicenter Study.

Lora-Tamayo J, Senneville É, Ribera A, Bernard L, Dupon M, Zeller V, Li HK, Arvieux C, Clauss M, Uçkay I, Vigante D, Ferry T, Iribarren JA, Peel TN, Sendi P, Miksic NG, Rodríguez-Pardo D, Del Toro MD, Fernández-Sampedro M, Dapunt U, Huotari K, Davis JS, Palomino J, Neut D, Clark BM, Gottlieb T, Trebše R, Soriano A, Bahamonde A, Guío L, Rico A, Salles MJC, Pais MJG, Benito N, Riera M, Gómez L, Aboltins CA, Esteban J, Horcajada JP, O'Connell K, Ferrari M, Skaliczki G, Juan RS, Cobo J, Sánchez-Somolinos M, Ramos A, Giannitsioti E, Jover-Sáenz A, Baraia-Etxaburu JM, Barbero JM, Choong PFM, Asseray N, Ansart S, Moal GL, Zimmerli W, Ariza J; Group of Investigators for Streptococcal Prosthetic Joint Infection .

Clin Infect Dis. 2017 Jun 15;64(12):1742-1752. doi: 10.1093/cid/cix227.

17.

Time-dependent association of glucocorticoids with adverse outcome in community-acquired pneumonia: a 6-year prospective cohort study.

Nickler M, Ottiger M, Steuer C, Kutz A, Christ-Crain M, Zimmerli W, Thomann R, Hoess C, Henzen C, Bernasconi L, Huber A, Mueller B, Schuetz P; ProHOSP Study Group.

Crit Care. 2017 Mar 24;21(1):72. doi: 10.1186/s13054-017-1656-7.

18.

Debridement and implant retention in the management of hip periprosthetic joint infection: outcomes following guided and rapid treatment at a single centre.

Sendi P, Lötscher PO, Kessler B, Graber P, Zimmerli W, Clauss M.

Bone Joint J. 2017 Mar;99-B(3):330-336. doi: 10.1302/0301-620X.99B3.BJJ-2016-0609.R1.

PMID:
28249972
19.

Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.

Vögeli A, Ottiger M, Meier MA, Steuer C, Bernasconi L, Kulkarni P, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Mueller B, Schuetz P.

Respir Res. 2017 Jan 23;18(1):25. doi: 10.1186/s12931-017-0502-4.

20.

Activation of the tryptophan/serotonin pathway is associated with severity and predicts outcomes in pneumonia: results of a long-term cohort study.

Meier MA, Ottiger M, Vögeli A, Steuer C, Bernasconi L, Thomann R, Christ-Crain M, Henzen C, Hoess C, Zimmerli W, Huber A, Mueller B, Schuetz P.

Clin Chem Lab Med. 2017 Jun 27;55(7):1060-1069. doi: 10.1515/cclm-2016-0912.

PMID:
28076309
21.
22.

The use of rifampin in staphylococcal orthopaedic-device-related infections.

Sendi P, Zimmerli W.

Clin Microbiol Infect. 2017 Jun;23(6):349-350. doi: 10.1016/j.cmi.2016.10.002. Epub 2016 Oct 13. No abstract available.

23.

Obesity paradox in patients with community-acquired pneumonia: Is inflammation the missing link?

Braun N, Hoess C, Kutz A, Christ-Crain M, Thomann R, Henzen C, Zimmerli W, Mueller B, Schuetz P.

Nutrition. 2017 Jan;33:304-310. doi: 10.1016/j.nut.2016.07.016. Epub 2016 Aug 9.

PMID:
27742103
24.

The National Early Warning Score (NEWS) for outcome prediction in emergency department patients with community-acquired pneumonia: results from a 6-year prospective cohort study.

Sbiti-Rohr D, Kutz A, Christ-Crain M, Thomann R, Zimmerli W, Hoess C, Henzen C, Mueller B, Schuetz P; ProHOSP Study Group.

BMJ Open. 2016 Sep 28;6(9):e011021. doi: 10.1136/bmjopen-2015-011021.

25.

Eradication of infection, survival, and radiological results of uncemented revision stems in infected total hip arthroplasties.

Born P, Ilchmann T, Zimmerli W, Zwicky L, Graber P, Ochsner PE, Clauss M.

Acta Orthop. 2016 Dec;87(6):637-643. Epub 2016 Sep 23.

26.

Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease.

Ottiger M, Nickler M, Steuer C, Odermatt J, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Mueller B, Schuetz P.

Eur J Intern Med. 2016 Dec;36:67-73. doi: 10.1016/j.ejim.2016.08.017. Epub 2016 Aug 24.

PMID:
27567042
27.

[Orthopaedic implant-associated infections: Update of antimicrobial therapy].

Zimmerli W.

Orthopade. 2015 Dec;44(12):961-6. doi: 10.1007/s00132-015-3184-y. Review. German.

PMID:
26542407
28.

One-stage revision of infected hip arthroplasty: outcome of 39 consecutive hips.

Ilchmann T, Zimmerli W, Ochsner PE, Kessler B, Zwicky L, Graber P, Clauss M.

Int Orthop. 2016 May;40(5):913-8. doi: 10.1007/s00264-015-2833-4. Epub 2015 Jul 30.

PMID:
26224611
29.

Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial.

Blum CA, Nigro N, Briel M, Schuetz P, Ullmer E, Suter-Widmer I, Winzeler B, Bingisser R, Elsaesser H, Drozdov D, Arici B, Urwyler SA, Refardt J, Tarr P, Wirz S, Thomann R, Baumgartner C, Duplain H, Burki D, Zimmerli W, Rodondi N, Mueller B, Christ-Crain M.

Lancet. 2015 Apr 18;385(9977):1511-8. doi: 10.1016/S0140-6736(14)62447-8. Epub 2015 Jan 19.

PMID:
25608756
30.

Clinical risk scores and blood biomarkers as predictors of long-term outcome in patients with community-acquired pneumonia: a 6-year prospective follow-up study.

Alan M, Grolimund E, Kutz A, Christ-Crain M, Thomann R, Falconnier C, Hoess C, Henzen C, Zimmerli W, Mueller B, Schuetz P; ProHOSP study group.

J Intern Med. 2015 Aug;278(2):174-84. doi: 10.1111/joim.12341. Epub 2015 Jan 27.

31.

Pre-analytic factors and initial biomarker levels in community-acquired pneumonia patients.

Kutz A, Grolimund E, Christ-Crain M, Thomann R, Falconnier C, Hoess C, Henzen C, Zimmerli W, Mueller B, Schuetz P; ProHOSP Study Group.

BMC Anesthesiol. 2014 Nov 15;14:102. doi: 10.1186/1471-2253-14-102. eCollection 2014.

32.

Long-term Prognosis in COPD Exacerbation: Role of Biomarkers, Clinical Variables and Exacerbation Type.

Grolimund E, Kutz A, Marlowe RJ, Vögeli A, Alan M, Christ-Crain M, Thomann R, Falconnier C, Hoess C, Henzen C, Zimmerli W, Mueller B, Schuetz P; ProHOSP Study Group.

COPD. 2015 Jun;12(3):295-305. doi: 10.3109/15412555.2014.949002. Epub 2014 Sep 17.

PMID:
25230352
33.

Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial.

Schuetz P, Kutz A, Grolimund E, Haubitz S, Demann D, Vögeli A, Hitz F, Christ-Crain M, Thomann R, Falconnier C, Hoess C, Henzen C, Marlowe RJ, Zimmerli W, Mueller B; ProHOSP Study Group.

Int J Cardiol. 2014 Aug 20;175(3):464-72. doi: 10.1016/j.ijcard.2014.06.022. Epub 2014 Jun 27.

PMID:
25005339
34.

Corticosteroid treatment for community-acquired pneumonia--the STEP trial: study protocol for a randomized controlled trial.

Blum CA, Nigro N, Winzeler B, Suter-Widmer I, Schuetz P, Briel M, Bingisser R, Zimmerli W, Ullmer E, Elsaesser H, Tarr P, Wirz S, Thomann R, Hofmann E, Rodondi N, Duplain H, Burki D, Mueller B, Christ-Crain M.

Trials. 2014 Jun 28;15:257. doi: 10.1186/1745-6215-15-257.

35.

The treatment and outcome of peri-prosthetic infection of the ankle: a single cohort-centre experience of 34 cases.

Kessler B, Knupp M, Graber P, Zwicky L, Hintermann B, Zimmerli W, Sendi P.

Bone Joint J. 2014 Jun;96-B(6):772-7. doi: 10.1302/0301-620X.96B6.33298.

PMID:
24891577
36.

Phenotypic and genotypic characterisation of Staphylococcus aureus causing musculoskeletal infections.

Post V, Wahl P, Uçkay I, Ochsner P, Zimmerli W, Corvec S, Loiez C, Richards RG, Moriarty TF.

Int J Med Microbiol. 2014 Jul;304(5-6):565-76. doi: 10.1016/j.ijmm.2014.03.003. Epub 2014 Apr 3.

PMID:
24768432
37.

Clinical presentation and treatment of orthopaedic implant-associated infection.

Zimmerli W.

J Intern Med. 2014 Aug;276(2):111-9. doi: 10.1111/joim.12233.

38.

Hyponatremia and anti-diuretic hormone in Legionnaires' disease.

Schuetz P, Haubitz S, Christ-Crain M, Albrich WC, Zimmerli W, Mueller B; ProHOSP Study Group.

BMC Infect Dis. 2013 Dec 11;13:585. doi: 10.1186/1471-2334-13-585.

39.

Effect of hyperglycaemia on inflammatory and stress responses and clinical outcome of pneumonia in non-critical-care inpatients: results from an observational cohort study.

Schuetz P, Friedli N, Grolimund E, Kutz A, Haubitz S, Christ-Crain M, Thomann R, Zimmerli W, Hoess C, Henzen C, Mueller B; ProHOSP Study Group.

Diabetologia. 2014 Feb;57(2):275-84. doi: 10.1007/s00125-013-3112-9. Epub 2013 Nov 24.

PMID:
24270903
40.

Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model.

Baldoni D, Furustrand Tafin U, Aeppli S, Angevaare E, Oliva A, Haschke M, Zimmerli W, Trampuz A.

Int J Antimicrob Agents. 2013 Sep;42(3):220-5. doi: 10.1016/j.ijantimicag.2013.05.019. Epub 2013 Jul 20.

PMID:
23880168
41.

Reply to Eisen and Denholm, Dauchy et al, Fierer, and Nguyen and Jones.

Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR.

Clin Infect Dis. 2013 Jul;57(1):162-4. doi: 10.1093/cid/cit189. Epub 2013 Mar 28. No abstract available.

PMID:
23537909
42.

Diagnosis of periprosthetic joint infections in clinical practice.

Sendi P, Zimmerli W.

Int J Artif Organs. 2012 Oct;35(10):913-22. doi: 10.5301/ijao.5000150. Epub 2012 Nov 12. Review.

PMID:
23371922
43.

Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America.

Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR; Infectious Diseases Society of America.

Clin Infect Dis. 2013 Jan;56(1):1-10. doi: 10.1093/cid/cis966.

PMID:
23230301
44.

Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America.

Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR; Infectious Diseases Society of America.

Clin Infect Dis. 2013 Jan;56(1):e1-e25. doi: 10.1093/cid/cis803. Epub 2012 Dec 6.

PMID:
23223583
45.

Orthopaedic device-associated infection.

Zimmerli W.

Clin Microbiol Infect. 2012 Dec;18(12):1160-1. doi: 10.1111/j.1469-0691.2012.04011.x. No abstract available.

46.

Risk factors for periprosthetic ankle joint infection: a case-control study.

Kessler B, Sendi P, Graber P, Knupp M, Zwicky L, Hintermann B, Zimmerli W.

J Bone Joint Surg Am. 2012 Oct 17;94(20):1871-6. doi: 10.2106/JBJS.K.00593.

PMID:
23079879
47.

Antimicrobial treatment concepts for orthopaedic device-related infection.

Sendi P, Zimmerli W.

Clin Microbiol Infect. 2012 Dec;18(12):1176-84. doi: 10.1111/1469-0691.12003. Epub 2012 Oct 10. Review.

48.

Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case-control study.

Achermann Y, Eigenmann K, Ledergerber B, Derksen L, Rafeiner P, Clauss M, Nüesch R, Zellweger C, Vogt M, Zimmerli W.

Infection. 2013 Apr;41(2):431-7. doi: 10.1007/s15010-012-0325-7. Epub 2012 Sep 19.

PMID:
22987291
49.

Predictors for length of hospital stay in patients with community-acquired pneumonia: results from a Swiss multicenter study.

Suter-Widmer I, Christ-Crain M, Zimmerli W, Albrich W, Mueller B, Schuetz P; ProHOSP Study Group.

BMC Pulm Med. 2012 May 20;12:21. doi: 10.1186/1471-2466-12-21.

50.

Pathogenesis and treatment concepts of orthopaedic biofilm infections.

Zimmerli W, Moser C.

FEMS Immunol Med Microbiol. 2012 Jul;65(2):158-68. doi: 10.1111/j.1574-695X.2012.00938.x. Epub 2012 Mar 15. Review.

Supplemental Content

Loading ...
Support Center